Sarah A. Cumming

2.0k total citations
44 papers, 1.0k citations indexed

About

Sarah A. Cumming is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Sarah A. Cumming has authored 44 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 31 papers in Cellular and Molecular Neuroscience and 18 papers in Neurology. Recurrent topics in Sarah A. Cumming's work include Genetic Neurodegenerative Diseases (31 papers), Mitochondrial Function and Pathology (16 papers) and Parkinson's Disease Mechanisms and Treatments (16 papers). Sarah A. Cumming is often cited by papers focused on Genetic Neurodegenerative Diseases (31 papers), Mitochondrial Function and Pathology (16 papers) and Parkinson's Disease Mechanisms and Treatments (16 papers). Sarah A. Cumming collaborates with scholars based in United Kingdom, United States and Netherlands. Sarah A. Cumming's co-authors include Darren G. Monckton, Sheila V. Graham, Wei Cui, Rosemary J. Akhurst, H. Elyse Ireland, Giuseppe Portella, Allan Balmain, Maria G. McPhillips, Steven G. Milligan and Mark Hamilton and has published in prestigious journals such as PLoS ONE, Neurology and Journal of Virology.

In The Last Decade

Sarah A. Cumming

44 papers receiving 991 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah A. Cumming United Kingdom 18 751 481 206 133 116 44 1.0k
Yung‐Nien Chang United States 15 553 0.7× 517 1.1× 169 0.8× 205 1.5× 121 1.0× 19 1.2k
Mathilde Girard France 14 662 0.9× 157 0.3× 69 0.3× 86 0.6× 40 0.3× 21 927
G. Cederquist United States 11 619 0.8× 157 0.3× 77 0.4× 70 0.5× 56 0.5× 27 1.0k
Daniel C. Worth United Kingdom 9 340 0.5× 279 0.6× 80 0.4× 52 0.4× 51 0.4× 10 791
Takeshi Asakura Japan 15 466 0.6× 138 0.3× 41 0.2× 134 1.0× 109 0.9× 44 921
Wei Jiao United States 13 596 0.8× 263 0.5× 47 0.2× 157 1.2× 93 0.8× 19 1.1k
Ché Serguera France 16 630 0.8× 153 0.3× 121 0.6× 76 0.6× 78 0.7× 29 1.1k
Louis Dye United States 11 853 1.1× 156 0.3× 52 0.3× 40 0.3× 278 2.4× 18 1.4k
Ian J. McGough United Kingdom 12 803 1.1× 98 0.2× 107 0.5× 85 0.6× 27 0.2× 13 1.1k
Ami Okada United States 16 792 1.1× 249 0.5× 78 0.4× 88 0.7× 119 1.0× 21 1.4k

Countries citing papers authored by Sarah A. Cumming

Since Specialization
Citations

This map shows the geographic impact of Sarah A. Cumming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah A. Cumming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah A. Cumming more than expected).

Fields of papers citing papers by Sarah A. Cumming

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah A. Cumming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah A. Cumming. The network helps show where Sarah A. Cumming may publish in the future.

Co-authorship network of co-authors of Sarah A. Cumming

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah A. Cumming. A scholar is included among the top collaborators of Sarah A. Cumming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah A. Cumming. Sarah A. Cumming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Willemse, Marieke, Sarah A. Cumming, Baziel G.M. van Engelen, et al.. (2024). Ameliorated cellular hallmarks of myotonic dystrophy in hybrid myotubes from patient and unaffected donor cells. Stem Cell Research & Therapy. 15(1). 302–302. 1 indexed citations
2.
Ciosi, Marc, Arkaitz Galbete, Sarah A. Cumming, et al.. (2024). Somatic CAG repeat instability in intermediate alleles of the HTT gene and its potential association with a clinical phenotype. European Journal of Human Genetics. 32(7). 770–778. 8 indexed citations
3.
Hamilton, Mark, António Atalaia, John McLean, et al.. (2022). Clinical and neuroradiological correlates of sleep in myotonic dystrophy type 1. Neuromuscular Disorders. 32(5). 377–389. 8 indexed citations
4.
Ciosi, Marc, Sarah A. Cumming, Afroditi Chatzi, et al.. (2021). Approaches to Sequence the HTT CAG Repeat Expansion and Quantify Repeat Length Variation. Journal of Huntington s Disease. 10(1). 53–74. 18 indexed citations
5.
Koscik, Timothy R., Ellen van der Plas, Laurie Gutmann, et al.. (2021). White matter microstructure relates to motor outcomes in myotonic dystrophy type 1 independently of disease duration and genetic burden. Scientific Reports. 11(1). 4886–4886. 5 indexed citations
6.
Moser, David J., Laurie Gutmann, Ellen van der Plas, et al.. (2021). Cognitive Deficits, Apathy, and Hypersomnolence Represent the Core Brain Symptoms of Adult-Onset Myotonic Dystrophy Type 1. Frontiers in Neurology. 12. 700796–700796. 17 indexed citations
7.
Miller, Norman, Ellen van der Plas, Mark Hamilton, et al.. (2020). Variant repeats within the DMPK CTG expansion protect function in myotonic dystrophy type 1. Neurology Genetics. 6(5). e504–e504. 19 indexed citations
8.
Almendrote, Míriam, Giuseppe Lucente, Alejandro Lucía, et al.. (2020). Preliminary Findings on CTG Expansion Determination in Different Tissues from Patients with Myotonic Dystrophy Type 1. Genes. 11(11). 1321–1321. 6 indexed citations
9.
Pintos‐Morell, Guillem, J Coll, Míriam Almendrote, et al.. (2020). The Need for Establishing a Universal CTG Sizing Method in Myotonic Dystrophy Type 1. Genes. 11(7). 757–757. 7 indexed citations
10.
Cooper, Anneli, Sarah A. Cumming, Berit Adam, et al.. (2020). Towards development of a statistical framework to evaluate myotonic dystrophy type 1 mRNA biomarkers in the context of a clinical trial. PLoS ONE. 15(4). e0231000–e0231000. 12 indexed citations
11.
Cumming, Sarah A., Gillian Stevens, Saif Razvi, et al.. (2020). A DM1 patient with CCG variant repeats: Reaching the diagnosis. Neuromuscular Disorders. 31(3). 232–238. 1 indexed citations
12.
Ciosi, Marc, Alastair Maxwell, Sarah A. Cumming, et al.. (2019). A genetic association study of glutamine-encoding DNA sequence structures, somatic CAG expansion, and DNA repair gene variants, with Huntington disease clinical outcomes. EBioMedicine. 48. 568–580. 101 indexed citations
13.
Plas, Ellen van der, Mark Hamilton, Norman Miller, et al.. (2019). Brain Structural Features of Myotonic Dystrophy Type 1 and their Relationship with CTG Repeats. Journal of Neuromuscular Diseases. 6(3). 321–332. 23 indexed citations
14.
Cumming, Sarah A., Cecilia Jimenez‐Moreno, Kees Okkersen, et al.. (2019). Genetic determinants of disease severity in the myotonic dystrophy type 1 OPTIMISTIC cohort. Neurology. 93(10). e995–e1009. 59 indexed citations
15.
Cumming, Sarah A., Mark Hamilton, Helen Gregory, et al.. (2018). De novo repeat interruptions are associated with reduced somatic instability and mild or absent clinical features in myotonic dystrophy type 1. European Journal of Human Genetics. 26(11). 1635–1647. 69 indexed citations
16.
Hamilton, Mark, Sarah A. Cumming, Helen Gregory, et al.. (2017). Elevated plasma levels of cardiac troponin-I predict left ventricular systolic dysfunction in patients with myotonic dystrophy type 1: A multicentre cohort follow-up study. PLoS ONE. 12(3). e0174166–e0174166. 29 indexed citations
17.
Agtmaal, Ellen L. van, Marieke Willemse, Sarah A. Cumming, et al.. (2017). CRISPR/Cas9-Induced (CTG⋅CAG) n Repeat Instability in the Myotonic Dystrophy Type 1 Locus: Implications for Therapeutic Genome Editing. Molecular Therapy. 25(1). 24–43. 95 indexed citations
18.
Sandison, Mairi E., Sarah A. Cumming, Walter Kölch, & Andrew R. Pitt. (2010). On-chip immunoprecipitation for protein purification. Lab on a Chip. 10(20). 2805–2805. 21 indexed citations
19.
Cumming, Sarah A. & Sheila V. Graham. (2005). Analysis of Regulatory Motifs Within HPV Transcripts. Humana Press eBooks. 119. 291–316. 2 indexed citations
20.
Attrill, Helen, Sarah A. Cumming, J. Barklie Clements, & Sheila V. Graham. (2002). The Herpes Simplex Virus Type 1 US11 Protein Binds the Coterminal UL12, UL13, and UL14 RNAs and Regulates UL13 Expression In Vivo. Journal of Virology. 76(16). 8090–8100. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yung‐Nien Chang Breakdown of academic impact, for papers by Mathilde Girard Breakdown of academic impact, for papers by G. Cederquist Breakdown of academic impact, for papers by Daniel C. Worth Breakdown of academic impact, for papers by Takeshi Asakura Breakdown of academic impact, for papers by Wei Jiao Breakdown of academic impact, for papers by Ché Serguera Breakdown of academic impact, for papers by Louis Dye Breakdown of academic impact, for papers by Ian J. McGough Breakdown of academic impact, for papers by Ami Okada
Rankless by CCL
2026